Charles River provides a multitude of products and services for the discovery and development of drugs and devices for the prevention and treatment of cardiovascular diseases. We are one of only a few contract research laboratories to offer disease models for evaluating potential therapies for activity against atherosclerosis, vascular inflammation and dyslipidemia.